Is Lavender Sleep Onset Randomized Trial safe?

Updated August 2026

Quick Answer

Lavender Sleep Onset Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: This shift has been driven by increasing clinical and preclinical evidence supporting anxiolytic effects of standardizedessential oil preparations.

Key Takeaways

  • 01This shift has been driven by increasing clinical and preclinical evidence supporting anxiolytic effects of standardizedessential oil preparations. [Nechepurenko Viktoriia (2026)]
  • 02Nevertheless, interest in its cultivation has increased significantly in recent years. [Nechepurenko Viktoriia (2026)]
  • 03The review seeks to integrate evidence on both volatile and nonvolatile fractions and to highlight opportunities for the valorization of lavender biomass within a sustainable, multi-sectoral framework. [Nechepurenko Viktoriia (2026)]
  • 04angustifolia Lavandula latifolia Lavender (genusL., family Lamiaceae) is one of the most extensively studied aromatic and medicinal plants. [Nechepurenko Viktoriia (2026)]
The current Migaku evidence database contains 2 reusable source documents for Lavender Sleep Onset Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - This shift has been driven by increasing clinical and preclinical evidence supporting anxiolytic effects of standardizedessential oil preparations. [Nechepurenko Viktoriia (2026); evidence level 3] - Nevertheless, interest in its cultivation has increased significantly in recent years. [Nechepurenko Viktoriia (2026); evidence level 3] - The review seeks to integrate evidence on both volatile and nonvolatile fractions and to highlight opportunities for the valorization of lavender biomass within a sustainable, multi-sectoral framework. [Nechepurenko Viktoriia (2026); evidence level 3] - angustifolia Lavandula latifolia Lavender (genusL., family Lamiaceae) is one of the most extensively studied aromatic and medicinal plants. [Nechepurenko Viktoriia (2026); evidence level 3] - While its pathogenesis is complex, increasing evidence supports the role of an imbalance between excitatory and inhibitory (E/I) neuronal activity in disease progression. [Piccialli I (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Lavandula angustifolia as a dual pharmacological system: from essential oil to polyphenol-rich biomass
  2. Exploring Linalool-Based Phytotherapy for Excitatory/Inhibitory Imbalance in Alzheimer's Disease: A Review of Lavender and Cannabis Therapeutic Effects on Sleep, Seizures, and Cognition.